MD Biosciences

10/27/2025

is just around the corner! We’re looking forward to connecting with fellow neuroscientists and showcasing our work. Visit us at booth #820 and let us know if you’ll be attending!

https://hubs.la/Q03Q2Wzj0

10/09/2025

Join us at the upcoming Boston Vendor Discovery Day on Tuesday, October 21! A great opportunity to connect with our team, discuss ongoing and future projects, and explore our scientific capabilities. Looking forward to seeing our fellow researchers and collaborators in the Boston community there.

Register here if you are interested in attending: https://hubs.la/Q03MJKyH0.

Join us at Scientist.com's R&D Vendor Discovery Day in Boston/Cambridge to connect with top vendors and explore new research opportunities!

09/16/2025

MD Biosciences is proud to have signed the Marseille Declaration, joining peers across pharma in committing to the highest standards of animal housing and use in research. This represents an important step in ensuring these standards are upheld both within organizations and through external partners.

Read more about the declaration here: https://hubs.la/Q03JwQLd0

MD Biosciences commits to high animal welfare standards by signing the Marseille Declaration, enhancing ethical practices in pharmaceutical research.

09/10/2025

Gait analysis is a powerful tool for evaluating peripheral nerve injuries and repair in translational pig models. Watch a clip from our recent webinar and access the full session here:

https://hubs.la/Q03Htjkq0

09/08/2025

We had the opportunity to present at NeuPSIG 2025, sharing our work on chemotherapy-induced peripheral neuropathy, neuroma characterization in minipigs, VEP/ERG monitoring in STZ models, and nerve interface procedures in rats. It was a great conference filled with valuable discussions and shared learning across the pain research community!

View all the posters we presented here: https://hubs.la/Q03HfWX00

09/04/2025

Our first day at NeuPSIG in Berlin! We presented on neuropathic pain research and had the chance to meet with others in the field.

08/26/2025

NeuPSIG 2025 is around the corner! Let us know if you’ll be attending, we’d love to meet.

Reach out to us here: https://hubs.la/Q03Fh1qy0

07/22/2025

Pleased to share our involvement in a recently published study investigating the pharmacokinetics and safety of a liposomal synthetic cannabidiol (LPT-CBD) formulation in pigs.

🔗 https://hubs.la/Q03ygJKR0

By Eyal Kalo, Keith Nelson & 8 more. In this work, liposomal CBD and its major human metabolite. 7-COOH-CBD was compared in rabbits and minipigs to provide initial data on PK and safety profiles.

07/15/2025

Translating preclinical findings into clinical success remains a major challenge in drug development.

At MD Biosciences, we focus on enhancing clinical relevance of preclinical models to better predict therapeutic outcomes and support more informed decision-making. Continue reading about our approach to preclinical study design here: https://hubs.la/Q03xklyn0

Enhance the clinical relevance of preclinical studies by integrating comorbidities, using back-translation, and employing large animal models for more accurate therapeutic predictions.

07/10/2025

Studying stroke and cortical injury requires models that reflect the complexity of neurodegenerative conditions.

Our models incorporate relevant variables such as age, s*x, and diabetes to better reflect the diversity and complexity of clinical settings.

🧠 Learn more about our neurodegeneration models: https://hubs.la/Q03wDxj10

🔗 Download our stroke and ischemia model datasheet: https://hubs.la/Q03wDrxV0

🧬 View the cortical trauma injury (CTI) datasheet: https://hubs.la/Q03wDsHW0

📄 Read our whitepaper on diversity in preclinical research: https://hubs.la/Q03wDsGW0

Neurological and CNS research services, featuring clinically-relevant read outs and endpoints. Models in Multiple Sclerosis, Parkinson's disease and more

06/25/2025

New MDB Blog Post: Behavioral assessments paired with physiological readouts enhance understanding of neurological disorders in preclinical models.

🔗https://hubs.la/Q03tBkCN0

Explore behavioral assessments in preclinical models to understand motor and cognitive deficits for neurological diseases.

06/18/2025

Our diabetic models in pigs and rodents are powerful tools to study neuropathy and impaired wound healing. With behavioral, electrophysiological, and biomarker readouts, they offer translational insights into disease mechanisms and therapeutic response. Learn more about the models here: https://hubs.la/Q03sxF8S0